Michael H. Davidson, Chief Executive Officer at NewAmsterdam Pharma, bought NAMS on Sep 14, 2026
Data as of Oct 16
▲ BUY$227K10,000 shares at $22.65Michael H. Davidson Chief Executive OfficerNAMS NewAmsterdam Pharma Co N.V.
- Traded
- Sep 14, 2026
- Disclosed
- Sep 15, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
NAMS since disclosure
−6.3%
Similar stocks (XLV) since disclosure
+5.4%
XLV — its sector index fund
Change in closing price from Sep 15, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.